Barrie, Canada Clinical Trials

A listing of Barrie, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 22 clinical trials
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab Followed by Maintenance Durvalumab Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients

This is a Phase III randomised, double-blind, multi-centre study to evaluate the efficacy and safety of durvalumab in combination with standard of care platinum based chemotherapy and bevacizumab followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian cancer.

Research Site
 (2.2 away) Contact site
  • 84 views
  • 25 Jul, 2021
  • +287 other locations
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description

Galderma Investigational Site 8586
 (2.4 away) Contact site
  • 21 views
  • 16 Jul, 2021
  • +470 other locations
Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

The main purpose of the study is to assess the efficacy and safety of nemolizumab after a 16-week treatment period in adult and adolescent subjects with moderate-to-severe atopic dermatitis (AD) not adequately controlled with topical treatments.

Galderma Investigational Site
 (2.4 away) Contact site
  • 95 views
  • 16 Jul, 2021
  • +458 other locations
Dose Optimization Study of Idelalisib in Follicular Lymphoma

The primary objective of this study is to establish a safe and effective dosing regimen of idelalisib in participants with relapsed or refractory follicular lymphoma (FL) who have no other therapeutic options.

follicular lymphoma
idelalisib
refractory follicular lymphoma
rituximab
ct scan
IHA Hematology Oncology Consultants
 (245.8 away) Contact site
  • 0 views
  • 25 Jul, 2021
  • +176 other locations
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

This 110-week study is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis.

atopy
lebrikizumab
topical agents
hormonal contraception
progestogen
Simcoderm Medical & Surgical Dermatology Centre
 (2.4 away) Contact site
  • 154 views
  • 25 Jul, 2021
  • +346 other locations
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

The purpose of study is to compare bladder intact-event free survival (BI-EFS) in participants receiving TAR-200 in combination with cetrelimab versus concurrent chemoradiotherapy.

bladder tumor
gemcitabine
neutrophil count
conjugated bilirubin
invasive bladder cancer
The Male/Female Health and Research Centre
 (2.4 away) Contact site
  • 0 views
  • 25 Jul, 2021
  • +312 other locations
A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab

This study is open to people with palmoplantar pustulosis who took part in previous clinical studies of a medicine called spesolimab. Participants who benefited from spesolimab treatment in the previous studies can join this study. The purpose of this study is to find out how safe spesolimab is and whether …

palmoplantar pustulosis
Simcoderm Medical and Surgical Dermatology Centre
 (1.6 away) Contact site
  • 7 views
  • 25 Jul, 2021
  • +66 other locations
A Research Study to Compare Two Types of Insulin a New Insulin Insulin Icodec and an Available Insulin Insulin Degludec in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

This study compares insulin icodec (a new insulin taken once a week) to insulin degludec (an insulin taken once daily which is already available on the market) in people with type 2 diabetes. The study will look at how well insulin icodec taken weekly controls blood sugar compared to insulin …

Novo Nordisk Investigational Site
 (2.4 away) Contact site
  • 0 views
  • 25 Jul, 2021
  • +86 other locations
A Study of TAR-200 in Combination With Cetrelimab TAR-200 Alone or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guerin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy

The purpose of this study is to evaluate the overall complete response (CR) rate in participants treated with TAR-200 in combination with cetrelimab (Cohort 1), or TAR-200 alone (Cohort 2), or cetrelimab alone (Cohort 3) with Carcinoma in Situ (CIS), with or without concomitant high-grade Ta or T1 papillary disease.

bladder tumor
carcinoma in situ
invasive bladder cancer
intravesical bcg
carcinoma
The Male/Female Health and Research Centre
 (2.4 away) Contact site
  • 0 views
  • 22 Jul, 2021
  • +176 other locations
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

This randomized phase III trial studies how well hypofractionated radiation therapy works in preventing recurrence in patients with stage IIa-IIIa cancer who have undergone mastectomy. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells that remain after surgery …

carcinoma in situ
skin carcinoma
lobular carcinoma
human chorionic gonadotropin
oophorectomy
Royal Victoria Regional Health Centre
 (2.2 away) Contact site
  • 335 views
  • 25 Jul, 2021
  • +911 other locations